Skip to main content
search

Strategic Leadership

Sign up

Latest resources

Featured resource

Upcoming strategic leadership webinars

Popular resources

Meet our experts at the following events

Conference

ACoP 2025

October 18 - 21, 2025
Conference

American College of Toxicology 2025 Annual Meeting

November 16 - 19, 2025 – Phoenix, Arizona – Booth 717
Conference

Redefining Every Stage of Investment (RESI) Seed to Exit

December 4, 2025

All Strategic Leadership resources

Redefining Every Stage of Investment (RESI) Seed to Exit

Certara Products, Certara Services, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Conference

The Pharmacometrics Africa Conference 2025 (PMXAC-2025)

Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Therapeutic Specialties, Conference

The Pursuit of Certainty: Integrated Evidence and the evolving drug development and reimbursement landscape

Certara Services, Drug Development, Model Informed Drug Development, Modeling and Simulation, Webinar

Blueprint for Biotech Success: De-risking Early Development to Secure Long-Term Value

Certara Services, Drug Development, Model Informed Drug Development, On-Demand Webinar

BioTechX US 2025

Certara Products - BaseCase, Certara Products - Simcyp, Certara Services, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - QSP, Conference

Replacing Traditional TQT Studies with Model-Based Concentration-QTc (C-QTc) Analysis for Cardiovascular Safety in Drug Development

Cardiovascular, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Safety, Drug-Drug Interactions (DDI), Model Informed Drug Development, Modeling and Simulation – PK/PD, Blog

Mechanistic Models at the Regulatory Frontier: Insights from EMA’s Qualification of the Simcyp® Simulator

Certara Products - Simcyp, Modeling and Simulation - PBPK, Webinar

Model-Based Meta-Analysis (MBMA) at GSK: Real-World Impact on Strategy and Trials

Certara Products, Certara Services, Drug Development, Model Informed Drug Development, Model-Based Meta-Analysis (MBMA), Modeling and Simulation, Therapeutic Specialties, Blog

MIDD Strategies for Preclinical and Clinical Translation: A Collaboration Between Clinical Pharmacologists and Modeling Disciplines

Certara Products, Certara Products - Simcyp, Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, On-Demand Webinar

Three Approaches to AI Adoption in Regulatory Writing

Certara Products, On-Demand Webinar

ADNCA Explained: The Next Generation of Non-Compartmental Analysis and the Top Questions Answered

Certara Products - Phoenix, Certara Products - Pinnacle 21, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Blog

The end of animal testing? Transitioning to models is promising — but no silver bullet

Certara Products - Simcyp, Homepage Latest, Modeling and Simulation, Press Coverage
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.